Answers are grounded in this paper and cite their sources.
Background Systemic inflammation contributes to the development of cardiovascular disease, but whether admission inflammatory biomarker levels predict long-term prognosis in critically ill cardiac patients remains debated. Methods We conducted a large, single-center observational study of consecutive ICCU admissions (January 2020–December 2021). Six biomarkers were evaluated for their ability to predict long-term all-cause mortality (median follow-up 4.7 years in the derivation cohort and 3.2 years in the validation cohort): neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), C-reactive protein-to-albumin ratio (CAR), fibrinogen-to-albumin ratio index (FARI), and immature platelet fraction (IPF). Optimal cutoffs were derived with receiver operating characteristic (ROC) analysis and the Youden index, and were then tested in an independent temporal validation cohort from the same center (2022 ICCU admissions). A composite score was built from the markers that remained significant in multivariable analysis. Results The derivation cohort included 2,131 patients and the validation cohort 1,013. Higher admission levels of most biomarkers were associated with higher long-term mortality. After multivariable adjustment, NLR (HR 1.68), SII (HR 1.40), CAR (HR 1.94), and FARI (HR 1.72) remained independent predictors of long-term mortality, beyond traditional risk factors. The composite score showed stepwise risk separation in unadjusted analysis; after adjustment, only scores of 3 and 4 remained independently associated with mortality (HR 2.58 and 3.31, respectively). Conclusions Elevated admission levels of NLR, SII, CAR, and FARI independently predicted long-term mortality in ICCU patients and may help refine risk assessment before discharge. A composite score based on these markers identified patients at the highest risk, but it did not reliably separate intermediate-risk groups. Further prospective studies, including external validation, are warranted.
No takes yet. Share an insight, caveat, or question.
Qadan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: